These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 37068372)

  • 1. Joint analysis identified FAP as a prognostic and diagnostic biomarker correlated immune infiltration in gastric cancer.
    Zhang K; Yue B; Duan X; Chen W; Dai X; Chen Y; Li X; Lu J
    Pathol Res Pract; 2023 May; 245():154462. PubMed ID: 37068372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of the collagen family as prognostic biomarkers and immune-associated targets in gastric cancer.
    Chen Y; Chen W; Dai X; Zhang C; Zhang Q; Lu J
    Int Immunopharmacol; 2020 Oct; 87():106798. PubMed ID: 32693357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and Verification of Potential Biomarkers in Gastric Cancer By Integrated Bioinformatic Analysis.
    Sun C; Chen Y; Kim NH; Lowe S; Ma S; Zhou Z; Bentley R; Chen YS; Tuason MW; Gu W; Bhan C; Tuason JPW; Thapa P; Cheng C; Zhou Q; Zhu Y
    Front Genet; 2022; 13():911740. PubMed ID: 35910202
    [No Abstract]   [Full Text] [Related]  

  • 4. ASPN Is a Potential Biomarker and Associated with Immune Infiltration in Endometriosis.
    Wang L; Sun J
    Genes (Basel); 2022 Jul; 13(8):. PubMed ID: 36011263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.
    Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L
    Front Immunol; 2019; 10():6. PubMed ID: 30761122
    [No Abstract]   [Full Text] [Related]  

  • 6.
    Xiao Y; Zhang H; Du G; Meng X; Wu T; Zhou Q; Wang Y; Tan B
    Technol Cancer Res Treat; 2020; 19():1533033820970684. PubMed ID: 33176601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TIMP2 is associated with prognosis and immune infiltrates of gastric and colon cancer.
    Jian F; Yanhong J; Limeng W; Guoping N; Yiqing T; Hao L; Zhaoji P
    Int Immunopharmacol; 2022 Sep; 110():109008. PubMed ID: 35792273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD44 is a prognostic biomarker and correlated with immune infiltrates in gastric cancer.
    Hou W; Kong L; Hou Z; Ji H
    BMC Med Genomics; 2022 Oct; 15(1):225. PubMed ID: 36316684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CTHRC1 is a Potential Prognostic Biomarker and Correlated with Macrophage Infiltration in Breast Cancer.
    Wang Z; Zhang S; Zheng C; Xia K; Sun L; Tang X; Zhou F; Ouyang Y; Tang F
    Int J Gen Med; 2022; 15():5701-5713. PubMed ID: 35755862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CTHRC1 Is Associated With Immune Escape and Poor Prognosis in Gastric Cancer.
    Hu Y; Huang L; Zhao K; Li Y; Givens NT; Heslin AJ; Deng Z; Cao L; Fang Y
    Anticancer Res; 2023 Jan; 43(1):115-126. PubMed ID: 36585164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and validation of the prognostic value of cyclic GMP-AMP synthase-stimulator of interferon (cGAS-STING) related genes in gastric cancer.
    Yang KS; Xu CQ; Lv J
    Bioengineered; 2021 Dec; 12(1):1238-1250. PubMed ID: 33843442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
    Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
    Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High expression of TMEM200A is associated with a poor prognosis and immune infiltration in gastric cancer.
    Deng H; Li T; Wei F; Han W; Xu X; Zhang Y
    Pathol Oncol Res; 2023; 29():1610893. PubMed ID: 36741965
    [No Abstract]   [Full Text] [Related]  

  • 14. PDGFRB is a potential prognostic biomarker and correlated with immune infiltrates in gastric cancer.
    Liu B; Xiao X; Lin Z; Lou Y; Zhao L
    Cancer Biomark; 2022; 34(2):251-264. PubMed ID: 34958001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CMA1 is potent prognostic marker and associates with immune infiltration in gastric cancer.
    Shi S; Ye S; Mao J; Ru Y; Lu Y; Wu X; Xu M; Zhu T; Wang Y; Chen Y; Tang X; Xi Y
    Autoimmunity; 2020 Jun; 53(4):210-217. PubMed ID: 32129682
    [No Abstract]   [Full Text] [Related]  

  • 16. Comprehensive analysis reveals
    Zhu Z; Xu J; Li L; Ye W; Chen B; Zeng J; Huang Z
    Transl Cancer Res; 2020 Jul; 9(7):4093-4110. PubMed ID: 35117779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers in Tumor Microenvironment? Upregulation of Fibroblast Activation Protein-α Correlates with Gastric Cancer Progression and Poor Prognosis.
    Hu M; Qian C; Hu Z; Fei B; Zhou H
    OMICS; 2017 Jan; 21(1):38-44. PubMed ID: 28206814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a Gene Prognostic Model of Gastric Cancer Based on Analysis of Tumor Mutation Burden.
    Ma W; Li W; Xu L; Liu L; Xia Y; Yang L; Da M
    Pathol Oncol Res; 2021; 27():1609852. PubMed ID: 34566519
    [No Abstract]   [Full Text] [Related]  

  • 19. BICC1 as a novel prognostic biomarker in gastric cancer correlating with immune infiltrates.
    Zhao R; Peng C; Song C; Zhao Q; Rong J; Wang H; Ding W; Wang F; Xie Y
    Int Immunopharmacol; 2020 Oct; 87():106828. PubMed ID: 32736193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Key Genes Associated with Prognosis and Tumor Infiltrating Immune Cells in Gastric Cancer Patients Identified by Cross-Database Analysis.
    Zhang T; Wang BF; Wang XY; Xiang L; Zheng P; Li HY; Tao PX; Wang DF; Gu BH; Chen H
    Cancer Biother Radiopharm; 2020 Nov; 35(9):696-710. PubMed ID: 32401038
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.